American Healthcare REIT vs Omega Healthcare Investors
AHR and OHI side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AHR and OHI compare
American Healthcare REIT and Omega Healthcare Investors are about the same size, with market caps of $12.6B and $14.2B.
On earnings, Omega Healthcare Investors is cheaper: it trades at 16.9× trailing earnings, against 85.2× for American Healthcare REIT.
American Healthcare REIT grew revenue faster over the last twelve months (16.4% versus 15.0% for Omega Healthcare Investors).
Omega Healthcare Investors keeps more of each dollar of sales as profit, with a net margin of 67.0% compared with 4.8% at American Healthcare REIT.
Both pay dividends: American Healthcare REIT yields 1.7% and Omega Healthcare Investors 4.3%.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AHR | OHI |
|---|---|---|
| Size and price | ||
| Market cap | $12.6B | $14.2B |
| Share price | $57.94 | $46.78 |
| Change, 1 year | 19.9% | 6.4% |
| Change, 5 years | – | 66.8% |
| Beta (5Y) | 0.07 | −0.13 |
| Employees | 121 | 69 |
| StockData Score | ||
| Total score | 11 | 11 |
| Valuation score | 0 | 3 (better) |
| Growth score | 4 (better) | 3 |
| Performance score | 4 (better) | 2 |
| Health score | 2 (better) | 0 |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | 85.2× | 16.9× (better) |
| P/S | 5.0× (better) | 11.1× |
| P/B | 3.4× | 2.6× (better) |
| EV/EBITDA | 17.3× | 10.0× (better) |
| PEG | – | 6.68 |
| Fair value | $22.83 | $51.90 |
| Margin of safety | −154% | 9.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 16.4% (better) | 15.0% |
| Revenue growth, 5Y average | 16.2% (better) | 5.9% |
| Net income growth (TTM) | – | 82.4% |
| EPS growth (TTM) | – | 73.1% |
| EPS growth, 5Y average | 53.1% (better) | 22.6% |
| Profitability | ||
| Gross margin | 21.2% | – |
| Operating margin | 19.2% | – |
| Net margin | 4.8% | 67.0% (better) |
| Return on equity | 4.0% | 16.5% (better) |
| Return on invested capital | 16.5% | – |
| Financial health | ||
| Interest coverage | 6.2× | – |
| Altman Z-score | 4.19 (better) | 2.80 |
| Piotroski F-score | 7 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | 1.7% | 4.3% (better) |
| Payout ratio | 148% | 92.6% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | 3.1% (better) | 0.00% |
| Buyback yield | −10.6% | – |
| Shareholder yield | −8.9% | 4.3% (better) |
| Ownership | ||
| Held by institutions | 103% | 81.8% |
| Held by insiders | 0.63% | 0.19% |
| Insider net buying, 12 months | −$4.6M | $0 (better) |
| Short interest, % of float | 15.5% | 4.9% |
Go deeper
- AHR stock overview
- AHR income statement
- AHR valuation and score
- OHI stock overview
- OHI income statement
- OHI valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.